Inflammatory
-
Estimating the economic burden of food-induced allergic reactions and anaphylaxis in the United States.
Patel DA, Holdford DA, Edwards E, Carroll NV. J Allergy Clin Immunol. 2011 Apr 11.
-
Cost effectiveness of adalimumab for the treatment of ankylosing spondylitis in the United Kingdom.
Botteman MF, Hay JW, Luo MP, Curry AS, Wong R, van Hout BA Rheumatology 2007;46(8):1320-1328
-
Evidence-based treatment of acute pancreatitis: antibiotic prophylaxis in necrotizing pancreatitis.
Besselink MG, van Santvoort HC, Buskens E, Gooszen HG. Ann Surg. 2006;244(4):637-8.
-
Minimally invasive 'step-up approach' versus maximal necrosectomy in patients with acute necrotising pancreatitis (PANTER trial): design and rationale of a randomised controlled multicenter trial.
Besselink MG, van Santvoort HC, Nieuwenhuijs VB, Boermeester MA, Bollen TL, Buskens E, Dejong CH, van Eijck CH, van Goor H et al. Dutch Acute Pancreatitis Study Group MO. BMC Surg. 2006;6(1):6.
-
Productivity costs among patients with rheumatoid arthritis: the influence of methods and sources to value loss of productivity.
Verstappen SM, Boonen A, Verkleij H, Bijlsma JW, Buskens E, Jacobs JW. Ann Rheum Dis. 2005;64(12):1754-60.
-
Working status among Dutch patients with rheumatoid arthritis: work disability and working conditions.
Verstappen SM, Boonen A, Bijlsma JW, Buskens E, Verkleij H, Schenk Y, van Albada-Kuipers GA, Hofman DM, Jacobson JW. Rheumatology (Oxford). 2005;44(2):202-6.
-
Assessing the cost-effectiveness of COX-2 specific inhibitors for arthritis in the Veterans' Health Administration.
Schaefer M, DeLattre M, Gao X, Stephens J, Botteman M, Morreale A. Curr Med Res Opin 2005; 21(1):47-60.
-
Determinants of direct costs in Dutch rheumatoid arthritis patients.
Verstappen SM, Verkleij H, Bijlsma JW, Buskens E, Kruize AA, Heurkens AH, Van Der Veen MJ, Jacobs JW. Ann Rheum Dis. 2004;63(7):817-24.
-
Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys.
Verstappen SM, Bijlsma JW, Verkleij H, Buskens E, Blaauw AA, ter Borg EJ, Jacobs JW; Utrecht Rheumatoid Arthritis Cohort Study Group. Arthritis Rheum. 2004;51(3):488-97.
-
Making progress in the management of postoperative pain: a review of the cyclooxygenase-2 specific inhibitors.
Stephens JM, Pashos CL, Haider S, Wong JM. Pharmacotherapy 2004;24(12):1714-1731.
-
Value of cyclooxygenase-2 inhibitors in the management of osteoarthritis.
Stephens JM, Bell CF, Wong JM, Pena BM, Haider S, Pashos CL. Expert Rev Pharmacoecon and Outcomes Res 2004;4(4):441-455.
-
Probiotic prophylaxis in patients with predicted severe acute pancreatitis (PROPATRIA): design and rationale of a double-blind, placebo-controlled randomised multicenter trial.
Besselink MG, Timmerman HM, Buskens E, Nieuwenhuijs VB, Akkermans LM, Gooszen HG; Dutch Acute Pancreatitis Study Group. BMC Surg 2004;4:12.
|
,
View by subject
|
